SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)
CUSIP: 868459108
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,572,193
- Total 13F shares
- 54,148,773
- Share change
- +811,578
- Total reported value
- $1,667,192,127
- Put/Call ratio
- 86%
- Price per share
- $30.79
- Number of holders
- 222
- Value change
- +$29,163,166
- Number of buys
- 98
- Number of sells
- 107
Quarterly Holders Quick Answers
What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 868459108:
Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
16%
|
8,994,226
|
$235,467,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.5%
|
5,454,555
|
$142,801,000 | — | 31 Mar 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
5.9%
|
3,412,000
|
$89,326,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.7%
|
2,132,092
|
$55,818,000 | — | 31 Mar 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
3.6%
|
2,083,718
|
$54,552,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
1,777,662
|
$46,539,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.1%
|
1,760,222
|
$46,083,000 | — | 31 Mar 2021 | |
| GW&K Investment Management, LLC |
13F
|
Company |
2.7%
|
1,573,411
|
$41,192,000 | — | 31 Mar 2021 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
2.1%
|
1,231,228
|
$32,234,000 | — | 31 Mar 2021 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
2%
|
1,140,519
|
$29,859,000 | — | 31 Mar 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
1.8%
|
1,035,089
|
$27,099,000 | — | 31 Mar 2021 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
1.8%
|
1,024,300
|
$26,816,000 | — | 31 Mar 2021 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
1.7%
|
973,293
|
$25,481,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
869,624
|
$22,766,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
1.4%
|
805,555
|
$21,089,000 | — | 31 Mar 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
1.3%
|
769,523
|
$20,146,000 | — | 31 Mar 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.3%
|
764,977
|
$20,027,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
727,283
|
$19,040,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
656,678
|
$17,192,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
608,383
|
$15,927,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
589,857
|
$15,442,000 | — | 31 Mar 2021 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.99%
|
569,461
|
$14,908,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.97%
|
560,258
|
$14,667,000 | — | 31 Mar 2021 | |
| Atle Fund Management AB |
13F
|
Company |
0.93%
|
534,000
|
$13,980,000 | — | 31 Mar 2021 | |
| NORGES BANK |
13F
|
Company |
0.84%
|
485,679
|
$12,715,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
450,929
|
$11,806,000 | — | 31 Mar 2021 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.75%
|
432,323
|
$11,318,000 | — | 31 Mar 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.75%
|
430,381
|
$11,267,000 | — | 31 Mar 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.73%
|
420,947
|
$11,021,000 | — | 31 Mar 2021 | |
| Bruce & Co., Inc. |
13F
|
Company |
0.7%
|
402,105
|
$10,527,000 | — | 31 Mar 2021 | |
| SCOUT INVESTMENTS, INC. |
13F
|
Company |
0.66%
|
379,968
|
$9,948,000 | — | 31 Mar 2021 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.65%
|
376,399
|
$9,854,000 | — | 31 Mar 2021 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.61%
|
350,784
|
$9,184,000 | — | 31 Mar 2021 | |
| S&T BANK/PA |
13F
|
Company |
0.56%
|
319,533
|
$8,365,000 | — | 31 Mar 2021 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.55%
|
318,706
|
$8,344,000 | — | 31 Mar 2021 | |
| Tributary Capital Management, LLC |
13F
|
Company |
0.55%
|
315,241
|
$8,253,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.51%
|
293,198
|
$7,676,000 | — | 31 Mar 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.5%
|
287,336
|
$7,522,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.44%
|
253,788
|
$6,645,000 | — | 31 Mar 2021 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.44%
|
252,989
|
$6,623,000 | — | 31 Mar 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.44%
|
251,604
|
$6,587,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.43%
|
250,367
|
$6,555,000 | — | 31 Mar 2021 | |
| PRUDENTIAL PLC |
13F
|
Company |
0.42%
|
242,100
|
$6,338,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.4%
|
232,800
|
$6,095,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.37%
|
212,176
|
$5,555,000 | — | 31 Mar 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.34%
|
195,947
|
$5,130,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.34%
|
194,671
|
$5,097,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.34%
|
193,113
|
$5,056,000 | — | 31 Mar 2021 | |
| Foundry Partners, LLC |
13F
|
Company |
0.33%
|
190,630
|
$4,991,000 | — | 31 Mar 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.31%
|
181,303
|
$4,748,000 | — | 31 Mar 2021 |
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2021
As of 30 Jun 2021,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,148,773 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, LOOMIS SAYLES & CO L P, GW&K Investment Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and Stephens Investment Management Group LLC.
This page lists
222
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
217
Q2 2021 holders
222
Holder diff
5
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.